Navigation Links
MinuteClinic Offers New Rapid Pink-Eye Test; Detects Viral Conjunctivitis Infections in Minutes
Date:8/11/2009

ATLANTA, Aug. 11 /PRNewswire/ -- MinuteClinic, the pioneer and largest provider of retail-based health care in the United States, is now offering a first-of-its kind rapid conjunctivitis (pink-eye) test at its 23 locations inside select CVS/pharmacy stores in the Atlanta area. The rapid test is a pilot project conducted in partnership with Rapid Pathogen Screening, Inc (RPS). MinuteClinic hopes to offer the test nationally at a future date in its clinic locations in 25 states.

The partnership makes the RPS Adeno Detector(TM) available to millions of Atlanta residents and allows MinuteClinic nurse practitioners to accurately diagnose whether a patient has viral or bacterial conjunctivitis. Practitioners can then identify a proper course of treatment and eliminate unnecessary antibiotic prescriptions when a viral condition exists.

"MinuteClinic patients will get on-the-spot results that provide a more precise pink-eye diagnosis," said Donna Haugland, MinuteClinic Chief Nursing Officer. "This helps prevent the overuse of antibiotics and can lead to prescription savings."

Conjunctivitis is an infectious -- and frequently highly-contagious -- condition that is most often caused by either a virus or bacteria. It is often spread among children in close environments such as schools, camps and recreational activities.

Until now, the accurate diagnosis and appropriate treatment of pink-eye has been difficult. While treatment with antibiotics is only necessary in 40 to 60 percent of cases, the majority of medical professionals prescribe antibiotics nearly 100 percent of the time. Indiscriminately prescribing antibiotics compounds the side effects associated with their overuse and increases patient resistance to these medications.

"Our goal was to develop new medical technology that improves patient outcomes and results in the highest level of care," said Rober
'/>"/>

SOURCE MinuteClinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CVS Caremark Names Andrew J. Sussman, M.D., as President/Chief Operating Officer of MinuteClinic
2. American CareSource Holdings Increases ACS Networks Convenience and Quality With MinuteClinic Signing
3. CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit
4. MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans
5. MinuteClinic is Educating Consumers About Swine Flu
6. MinuteClinic Becomes Participating Provider With Highmark Inc.
7. MinuteClinic Becomes Participating Provider for Health Net Federal Services/TRICARE North, Insurer for Military Families
8. Cleveland Clinic Enters into Agreement with MinuteClinic
9. MinuteClinic Becomes Participating Provider With Preferred Blue Network of BlueCross BlueShield of South Carolina
10. MinuteClinic Becomes Participating Provider With Horizon Blue Cross Blue Shield of New Jersey
11. MinuteClinic Becomes Participating Provider With Blue Cross and Blue Shield of Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2010)... Dotinga HealthDay Reporter , , THURSDAY, Sept. 2 ... news stories about the young, possibly because it makes ... , , "The more time they spent with negative news ... may get some self-esteem boost out of this," said ... State University,s School of Communication. As for young ...
(Date:9/2/2010)... of as trunks in the tree of life. All multi-cellular ... variety other cellskidney, brain, heart or skin, for example. One ... virtually any cell type in the body, making them a ... of age-old diseases or even regrowing defective body parts. , ... shown for the first time that a gene called Myc ...
(Date:9/2/2010)... emergency medical services (EMS) agencies from across the country ... a tool that might point to potential patient safety ... School of Medicine. , The study , ... Prehospital Emergency Care and now available online, analyzed ... and Canada. Researchers adapted a survey used in other ...
(Date:9/2/2010)... treatments build on the benefits of drug therapy, ... and Dr. Kenneth Holroyd from Ohio University in ... various treatment combinations for severe migraine drug ... that those patients receiving the behavioral management program ... their ability to use behavioral skills to effectively ...
(Date:9/1/2010)... New research from the University of New Hampshire ... teenagers who use marijuana are more likely to move ... is overblown. , Whether teenagers who smoked pot ... more to do with life factors such as employment ... fact, the strongest predictor of whether someone will use ...
Breaking Medicine News(10 mins):Health News:Seniors Get Boost From Bad News About the Young 2Health News:Study finds that cancer-causing gene crucial in stem cell development 2Health News:Study finds that cancer-causing gene crucial in stem cell development 3Health News:Safety cultures in EMS agencies vary widely, Pitt study finds 2Health News:Head start for migraine sufferers 2Health News:Risk of marijuana's 'gateway effect' overblown, new UNH research shows 2
... a rate not seen in more than twenty years, creating a ... for small business is being called a top priority at a ... (NFIB) and America,s Health Insurance Plans (AHIP). , ... ...
... benefits can last for years, researchers say , , MONDAY, March ... play: A new study finds the pastime can help adults ... the first parts of vision to be affected by aging. ... minor changes in shades of grey against a uniform background ...
... 44% Over Prior YearVANCOUVER, March 30 /PRNewswire-FirstCall/ - Response ... recorded total revenues of $5,876,337 and a net loss ... ended December 31, 2008. Additionally, the Company announced that ... million in working capital. For a further discussion of ...
... offer improved aesthetic results will help drive the dental ... Mass., March 30 According to Millennium Research Group,s ... Implants 2009 report, although the current economic crisis ... term, the US dental implant market will recover after ...
... ANN ARBOR, Mich., March 30 A ... effective, cheaper medications may create barriers that lead people ... Thomson Reuters study. As a result, patients ultimately require ... called "step therapy," requires health plan members to try ...
... Well Tolerated Throughout Two-Year Study- Conference Call Scheduled ... March 30, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ... results from BLOOM (Behavioral modification and Lorcaserin for ... pivotal trials evaluating the safety and efficacy of ...
Other Medicine News:Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 2Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 3Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 4Health News:Response Biomedical Corporation Reports 2008 Financial Results 2Health News:Response Biomedical Corporation Reports 2008 Financial Results 3Health News:Response Biomedical Corporation Reports 2008 Financial Results 4Health News:Response Biomedical Corporation Reports 2008 Financial Results 5Health News:Dental Implant Market to Exceed $1 Billion by 2013 Despite Current Economic Slowdown 2Health News:Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers 2Health News:Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers 3Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 2Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 3Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 4Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 5Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 6Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 7Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 8Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 9Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 10Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 11
(Date:9/2/2010)... DALLAS, Texas, September 2, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; ... first one. for (var r in data.results) { first_result = data.results[r]; break; } for ...
(Date:9/2/2010)... Schein, Inc. (Nasdaq: HSIC ), the ... to office-based practitioners, is helping a record number ... and carrying backpacks filled with school supplies and ... Back-to-School program.  This year, the Back-to-School program is ... and Canadian cities.  Since its creation in 1998, ...
(Date:9/1/2010)... CITY, Fla., Sept. 1 Gulf Coast ... of Radiology-accredited radiation oncology center, introduces the Elekta ... at the center,s Open House on Thursday, September ...  Gulf Coast Cancer Treatment Center (GCCTC) is located ... oncologists Dr. D.B. Hurst and Dr. Jefferson Trupp ...
Breaking Medicine Technology:Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 2Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 3Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 4Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 5Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 6Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 7Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 813th Annual Henry Schein Back-to-School Program Serves Record Number of Children 213th Annual Henry Schein Back-to-School Program Serves Record Number of Children 3Open House at Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® to Community 2ApexTwo and SugarCRM Announce New Implementation Partnership 71891 1ApexTwo and SugarCRM Announce New Implementation Partnership 71891 2 2418 5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C Section 71887 1 2418 5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C Section 71887 2Cost Savings from Mobile Health Monitoring to Reach 241 9 billion to 245 8 Billion Globally by 2014 says Juniper Research 71883 1Cost Savings from Mobile Health Monitoring to Reach 241 9 billion to 245 8 Billion Globally by 2014 says Juniper Research 71883 2Cost Savings from Mobile Health Monitoring to Reach 241 9 billion to 245 8 Billion Globally by 2014 says Juniper Research 71883 3
... is Prostate Cancer Awareness Month, MIAMI and PALM ... Month, and the CyberKnife Centers of Miami and,Palm Beach ... surgery and long treatment courses of radiation. Prostate cancer ... the US., Morse CyberKnife CEO, James G. Schwade, ...
... N.Y., Sept. 2 The many recent reports,documenting ... in,animal models of human disease may actually be ... siRNA to activate an immune,response, according to a ... 9) of ,Human Gene Therapy, a peer-reviewed journal ...
Other Medicine Technology:Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy' 2Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy' 3
Finstruments 96 well washer and Cellwasher. Multi-function with touch programmable display....
The Finstrip combines high performance and flexibility with reliability, simplicity and ease of use....
... has set a standard for ultra-fast washing ... instrument not only processes all 384 wells ... further boost wash performance. This wash procedure ... times as no transport steps to index ...
... Bio-Rad's Model 1575 immunowash ... control of needle position ... routines and maximize wash ... a large choice of ...
Medicine Products: